Interim efficacy analysis of the phase 2 dose de-escalation trial of stereotactic arrhythmia radioablation for ventricular tachycardia (StAR-VT)
31 March 2025 (08:00 - 17:45)
Organised by: 
Abstract
About the speaker
McGill University Health Centre, Montreal (Canada)
146 More presentations in this session
Mr S. Majumder (Minneapolis, US)
Miss K. Bulatova (Basel, CH)
Mr Y. Turubayev (Astana, KZ)
Access the full session
The Event
EHRA 2025
31 March 2025
08:00 CET
You may be interested in
Congress Session
Congress Presentation
